When Medtronic announced in January that SYMPLICITY HTN-3 failed to meet its efficacy endpoint, it sounded like the beginning of the end for renal denervation as a treatment for uncontrolled hypertension.

The heart team approach is transforming how cardiovascular specialists and staff interact and provide patient care, but it also poses challenges in daily practice.

When the Heart Rhythm Society’s scientific session kicks off next week, it likely will include a healthy contingent of presenters and attendees from outside the U.S. The international mix is especially beneficial in fields that depend on innovative technologies. 

SCAI will launch a leadership boot camp for cath lab directors and managers at its scientific session May 28-31 in Las Vegas.

Some experts suggest FFR has a role in CABG because of its potential to spare patients a complicated surgery as well as cut costs.

The Heart Rhythm Society will name two winners of its Young Investigator Awards on May 9 at a ceremony during its 2014 annual scientific session in San Francisco.

Fears that physicians may be treating patients who are suitable candidates for standard care with less invasive transcatheter aortic valve replacement (TAVR) may be allayed, based on results presented April 28 at the American Association of Thoracic Surgery meeting in Toronto.

A patient who is on a heart transplant waiting list became the first participant with a total artificial heart to complete the 4.2-mile course at the annual Pat’s Run event in Tucson, Ariz. AZ Central Channel i2 News reported on the accomplishment.